Key points † Catecholamines are routinely used in the intensive care setting. † In dogs, the effects of epinephrine and norepinephrine vary depending on the type of anaesthetic. † The local effects of the catecholamines (in the gastric mucosa) were not predictable from the systemic effects.
sive care settings, where critically ill patients frequently present with profound inflammatory vasodysregulation (such as in sepsis), patients receiving norepinephrine or epinephrine for perioperative haemodynamic support during anaesthetic procedures often present without inflammatory vasodysregulation. However, in this latter group, the anaesthetics used may affect the cardiocirculatory system differently and alter the responsiveness to vasoactive drugs, such as catecholamines. 8 Thus, we studied the systemic and regional gastric mucosal effects of epinephrine and norepinephrine under two classes of anaesthetics, the volatile agent sevoflurane and the i.v. anaesthetic, propofol, in healthy animals. bodyweight, obtained from the university animal experiment facility of Dusseldorf, Germany) that were treated in accordance with the National Institutes of Health guidelines for animal care and with approval of the local District Governmental Animal Investigation Committee (registration code 50.05-230-74/05). Each experiment on each dog was scheduled ≥2 weeks apart to exclude carry-over effects between the experiments. During this study period, the animals were under regular veterinary supervision at the university animal experiment facility.
For the continuous measurement of cardiac output (CO), ultrasonic flow transducers (20 mm S-series, Transonic, Ithaca, NY, USA) were chronically implanted around the pulmonary artery and calibrated, at least 4 weeks before the experiments. 9 Before the experiments, food was withheld for 12 h with water ad libitum to ensure gastric depletion and to exclude gastric mucosal perfusion/oxygenation changes by digestive activity. The experiments were performed under general anaesthesia with either sevoflurane or propofol as described below, with mechanical ventilation (laryngoscopy-guided tracheal intubation; cuffed 8.5 mm tracheal tube; FI O 2 0.30 in N 2 ; tidal volume 12.5 ml kg 21 , 10 ventilatory frequency 20 min 21 ) maintaining normocapnia as verified by continuous capnography (end-tidal CO 2 35 mm Hg) and intermittent arterial blood gas analysis.
Measurements

Gastric mucosal oxygenation
Gastric mucosal oxygenation was continuously assessed by reflectance spectrophotometry (EMPHO II, BGT, Friedrichshafen, Germany), as detailed previously. 9 Briefly, light (502 -628 nm) is transmitted to the tissue of interest via a micro light guide, and the reflected light is analysed for the percentage of oxygenated microvascular haemoglobin (mHbO 2 ). The flexible light guide probe (outer diameter 2.0 mm) was introduced into the stomach via an orogastric silicone tube (14 Charrière) . During the experiments, the correct probe position was confirmed continuously by online evaluation of the signal quality (EMPHO II software, version 2.0) as detailed previously. 11 The mHbO 2 values reported resemble the averaged mHbO 2 of the last 4 min (150 spectra, 1.6 seconds each) of each intervention under steady-state conditions.
Systemic oxygen consumption
Systemic oxygen consumption (VO 2 ) was measured continuously by indirect calorimetry (Deltatrac-II metabolic monitor, Datex, Helsinki, Finland) and thus was methodologically independent from determination of CO and systemic oxygen transport (DO 2 ), as detailed previously for anaesthetized dogs. 9 
Systemic haemodynamics and oxygenation
We continuously measured heart rate (HR, ECG), mean arterial (aortic) and central venous (right atrial) pressures (MAP and CVP, respectively, using saline-filled sterile catheters and appropriate transducers, Gould-Statham, P23ID, Elk ; ABL-700). According to standard formulae, we calculated systemic vascular resistance (SVR), arterial oxygen content (CaO 2 ), and systemic oxygen transport (DO 2 ¼CO CaO 2 ).
Experimental programme
The animals were randomized using opaque envelopes to receive anaesthesia with sevoflurane or propofol. After induction (propofol 4 mg kg 21 in both groups), 12 catheters were inserted (right atrial position of the saline central venous catheter verified by fluoroscopy) and 30 min were allowed to establish steady-state conditions of the measured variables. Blood was sampled for baseline analysis, and thereafter, a second randomization using opaque envelopes was performed to allocate the dogs to the study groups, that is, epinephrine or norepinephrine. Each dog underwent each experimental combination. 
Type of anaesthesia
Statistical analysis
All data are presented as median [inter-quartile range (IQR)] for n¼6 animals per group (total 24 experiments). Comparisons were performed between drugs (i.e. epinephrine vs norepinephrine) using the Mann-Whitney test, and within each group (i.e. baseline vs respective drug infusion steps) using the Friedman test, and corrected for multiple comparisons using Dunn's post hoc test. Significance was assumed at P,0.05.
Results
The main result of our study is that norepinephrine, but not epinephrine, significantly increases microvascular gastric mucosal oxygenation (mHbO 2 ) during sevoflurane anaesthesia, whereas both catecholamines fail to increase mHbO 2 during propofol anaesthesia.
Gastric mucosal and systemic O 2 -related variables
During sevoflurane anaesthesia, epinephrine elicited a dosedependent, biphasic change in regional mHbO 2 was lower with norepinephrine than with epinephrine at all dosages, only norepinephrine significantly increased mHbO 2 .
In contrast to the significant and opposing effects of epinephrine and norepinephrine during sevoflurane anaesthesia, both catecholamines failed to significantly affect mHbO 2 during propofol anaesthesia (Fig. 1B) : both epinephrine and norepinephrine maintained mHbO 2 stable at baseline values at all doses. However, similar to sevoflurane, in animals undergoing propofol anaesthesia, epinephrine resulted in a doubling of DO 2 (P,0.0001), while little effect was seen with norepinephrine on DO 2 .
The relationship between regional (mHbO 2 ) and systemic oxygenation (DO 2 ) markedly differed between the groups. During sevoflurane anaesthesia, norepinephrine significantly increased mHbO 2 with only minor changes in DO 2 , whereas epinephrine markedly increased DO 2 without increasing mHbO 2 . In contrast, during propofol anaesthesia, despite marked changes in DO 2 , there were no significant effects on mHbO 2 . Thus, mHbO 2 cannot be deduced from DO 2 and vice versa.
Furthermore, the relationship between regional oxygenation (mHbO 2 ) and MAP markedly differed between the groups. During sevoflurane anaesthesia, only norepinephrine increased mHbO 2 pressure dependently, whereas in contrast during propofol anaesthesia, the marked and significant changes in MAP were not associated with changes in mHbO 2 . Thus, mHbO 2 cannot be deduced from MAP.
Systemic haemodynamics
The haemodynamic data are shown in Supplementary Table S2 ). At lower doses, epinephrine tended to decrease SVR, with a return towards baseline at the higher doses. In addition, epinephrine failed to increase MAP at the lowest dose, but increased MAP at higher doses. Thus, epinephrine at low doses acted as an inodilator, with accentuated vasoconstriction at the high doses. Norepinephrine, in contrast, acted predominantly as a vasopressor, increasing MAP even at the lowest dose, together with a reduction in HR. In parallel with this reduction of HR, norepinephrine also increased SVR at higher doses. Table S3 ).
Ventilation-derived variables
Electrolytes and metabolites
Arterial serum electrolyte concentrations were maintained in epinephrine-and norepinephrine-treated animals with both anaesthetics throughout the entire experiment (Supplementary Table S3 ). Epinephrine and norepinephrine both resulted in preserved arterial serum glucose concentrations between 90 and 130 mg dl 21 with both anaesthetics (Supplementary Table S3 ). Epinephrine treatment significantly increased arterial lactate both during sevoflurane (P¼0.0028) and propofol anaesthesia (P,0.0001), whereas norepinephrine resulted in maintenance of lactate under both sevoflurane and propofol anaesthesia (Fig. 3 ).
Discussion
Experimental model
Repetitive experiments were performed in a randomized fashion on healthy, chronically instrumented dogs with intervals of ≥2 weeks to exclude carry-over effects and minimize interindividual differences. Furthermore, the use of chronically instrumented animals avoided acute surgical instrumentation and thus confounders like stress responses to surgery, inducing elevated endogenous levels of epinephrine and norepinephrine. In addition, our model allowed us to study animals undergoing anaesthesia alone, without the need for analgesics 14 or other confounding drugs. Although this reduction of confounding factors appears advantageous in the present experimental study, it does not reflect the complexity of clinical anaesthesia, thus limiting extrapolation of our data to the clinical setting where epinephrine or norepinephrine may be used, for example, anaphylaxis, haemorrhage, sepsis, cardiac failure, burns, etc. All of these settings require specific animal models to extend our findings on the interaction between anaesthesia and catecholamine to the pathology of hypotension.
Type of anaesthesia
The dosages of the respective anaesthetics sevoflurane and propofol 9 12 15 16 resulted in a comparable, stable level of anaesthesia, as judged by toleration of mechanical ventilation (without need for any other drugs) and loss of pharyngeal and eyelash reflexes, respectively (Ramsay sedation score ≥4). In a recent study using a similar canine model, the same dosages of sevoflurane and propofol were applied, with depth of anaesthesia monitored by the EEG-derived bispectral index. 16 The anaesthetic dosages appear relatively high compared with clinical use, but are explained by increased anaesthetic requirements in dogs 12 and deliberate avoidance of other confounding drugs in our monoanaesthesia model, that is, no premedication and no analgesia. Compared with the awake state, anaesthesia induces cardiovascular depression, depending on anaesthetic regimen applied. In our previous studies, we reported an awake MAP of 100 mm Hg and CO of 100 ml kg 21 min 21 in similarly instrumented dogs of comparable weight. 17 18 Compared with these data, sevoflurane in the present study markedly depressed the cardiovascular system, whereas propofol had only moderate impact, although yielding the same level of anaesthesia. In addition, the selected sevoflurane and propofol dosages were also matched to achieve the same baseline levels in mHbO 2 , as evident from the almost identical baseline mHbO 2 during sevoflurane and propofol anaesthesia.
Reflectance spectroscopy
Gastric mucosal mHbO 2 was continuously measured by reflectance spectrophotometry, a method previously detailed by us 15 19 and others. 20 21 As described before, the light guide was non-traumatically introduced via an orogastric tube into the stomach. 9 22 Reflectance spectrophotometry allows direct determination of intracapillary haemoglobin oxygen saturation, representing microcirculatory oxygen availability. 20 Furthermore, gastric endoluminal reflectance spectroscopy is reported to predominantly measure capillary haemoglobin oxygenation of the mucosa rather than of outer wall layers. 23 Spectrophotometry reliably detects even clinically asymptomatic reductions in gastric mucosal oxygenation 24 and correlates with the morphological severity and extent of gastric mucosal tissue injury. 25 The values of mHbO 2 at baseline observed in our study are in accordance with previous studies on gastrointestinal mucosa oxygenation in dogs 9 and pigs. 21 26 27 Interpretation of results
We found that norepinephrine, but not epinephrine, increases mHbO 2 during sevoflurane anaesthesia in dogs, whereas both catecholamines fail to increase mHbO 2 during propofol anaesthesia. In detail, epinephrine depresses mHbO 2 at low dosages during sevoflurane with only a return to baseline values at higher epinephrine dosages. Moreover, this biphasic response in regional mHbO 2 contrasts the observed, dose-dependent increase in systemic DO 2 , suggesting interference from other factors such as vascular and metabolic effects. 28 In line with activation of cardiac b 1 -and vasodilatory b 2 -adrenoceptors, epinephrine at low dose increased CO and DO 2 at stable MAP and tended to decrease SVR. Thus, epinephrine should increase mHbO 2 both via an increased systemic DO 2 and regional vasodilation, 29 particularly at low doses where these b-effects
are not counteracted by a-adrenoceptor-mediated vasoconstriction. However, in line with our findings, activation of b 2 -adrenoceptors by epinephrine decreases splanchnic blood volume, 30 for example, by relaxing hepatic resistance vessels.
3 Additionally, at the intramural level, our contrasting findings could result in part from a layer-specific adrenoceptor distribution within the gastrointestinal wall. 31 Sympathic nerve fibres with their adrenoceptors are predominantly located within the outer gut layers, that is, the muscularis and submucosa. 31 Thus, low-dose epinephrine predominantly stimulates b-adrenoceptors and could thereby increase perfusion of outer gut layers, thus causing reduction of mucosal perfusion. At higher doses, however, epinephrine also stimulates vasoconstrictive a 1 -adrenoceptors, thus redirecting blood flow towards the mucosa and thereby restoring mucosal oxygenation. Compatible with this finding, a further increase in epinephrine dosage might eventually increase mHbO 2 above baseline, however, with aggravated systemic effects. This is supported by data from acutely instrumented pigs, demonstrating that higher epinephrine dosages increase mucosal oxygenation, 26 with rather marked haemodynamic effects. Norepinephrine markedly increased mHbO 2 during sevoflurane anaesthesia with only minor changes in DO 2 . Again, this agrees with a preferential location of sympathic nerve terminals within the outer gut wall. 31 Since norepinephrine even at low doses predominantly activates a-adrenoceptors, we suggest that norepinephrine induces an intramural redistribution of blood flow towards the gut mucosa, thereby increasing mucosal mHbO 2 . However, our findings of increased mHbO 2 with norepinephrine, contrasts with experiments in dogs or rats, reporting a norepinephrine-induced depression of gut mucosal oxygenation and perfusion, respectively. 32 Fuelled by those studies, norepinephrine was traditionally regarded only as a last resort vasopressor in hypotensive patients, leading to acceptance of lower arterial pressures to avoid norepinephrine and its assumed detrimental effects on splanchnic perfusion. However, this concept is currently challenged at least for septic patients, 33 since septic vasodilatation may counteract a critical, norepinephrine-induced, splanchnic vasoconstriction. Our findings may extend this promotion of norepinephrine even to anaesthetized subjects without grossly impaired vasoregulation. In accordance with our propofol anaesthetized animals, norepinephrine also preserved mucosal mHbO 2 in acutely instrumented pigs anaesthetized with ketamine, midazolam, and fentanyl. 27 In the present study, norepinephrine probably did not induce detrimental vasoconstriction in organs, necessitating the onset of anaerobic metabolism, since norepinephrine preserved (and even decreased) lactate levels. In striking contrast, epinephrine markedly increased arterial lactate levels, a finding also supported by others. 34 Although increasing lactate levels are generally attributed to anaerobic metabolism, epinephrine may induce hyperlactataemia in the absence of anaerobic metabolism, by increasing glycolysis 35 and glycogenolysis. In our study, the similar course of arterial pH at stable Pa CO 2 with both epinephrine and norepinephrine, together with a hyperglycaemic trend with epinephrine, is compatible with this concept. Supporting the crucial role of splanchnic perfusion and oxygenation in critical illness, several studies have investigated the splanchnic effects of vasoactive drugs. However, the majority of studies did not compare the effects of epinephrine and norepinephrine, 33 36 -38 and were mostly performed in settings of severely impaired vasoregulation, such as sepsis, trauma, or after cardiac surgery, 39 40 limiting a comparison of those data with our findings. Moreover, both animal 41 42 and patient studies are highly inconsistent, with reports of beneficial 43 44 and detrimental 34 41 45 46 effects of epinephrine on splanchnic perfusion and oxygenation in sepsis. In contradiction to traditional clinical concepts, but in line with our findings, norepinephrine is reported to preserve or even improve tonometrically assessed splanchnic mucosal perfusion after cardiac surgery 39 40 and in septic patients, 47 respectively.
Summarizing these contradicting studies, it was concluded that effects of vasoactive agents on tonometrically assessed mucosal perfusion are unpredictable, 48 necessitating further studies on this topic. 49 Since tonometry is only an indirect estimate of mucosal perfusion complicated by multiple confounders, 50 reflection spectrophotometry as used in our study may serve as a more direct method to measure mucosal oxygenation. 20 23 Furthermore, in extension to the mentioned patient groups with severely impaired vasoregulation, the present study addresses the large population of patients without severely disturbed (inflammatory) vasoregulation undergoing anaesthesia.
Type of anaesthesia
Epinephrine and norepinephrine are used clinically for haemodynamic support, often in sedated or anaesthetized patients. As expected, sevoflurane and propofol per se induced different systemic haemodynamics. Limited reports suggest different microcirculatory effects, for example, within the cochlea, 51 limb, 52 or finger. 53 Interestingly, although epinephrine and norepinephrine induced their expected systemic haemodynamic response similarly during either sevoflurane or propofol anaesthesia, significant regional effects only occurred in animals undergoing anaesthesia with sevoflurane and neither catecholamines significantly affected mHbO 2 during propofol anaesthesia. Thus, propofol appears to blunt the regional response to epinephrine and norepinephrine. This finding is compatible with others also reporting significant differences in regional (cerebral) catecholamine effects, 8 depending on the type of anaesthesia.
The measured key modulators of vascular tone did not differ between the sevoflurane and propofol groups, suggesting that other, anaesthetic specific, mechanisms cause this difference in catecholamine response, with better preservation of regional metabolic or vascular autoregulation during propofol anaesthesia. 8 A recent study comparing the effects of sevoflurane-and propofol-based anaesthesia on autonomic function reports that both agents elicit similar central, cardiac autonomic effects, but that sevoflurane induces a greater reduction in sympathetic nervous modulation of the peripheral vasculature. 54 This may permit a more unmodulated peripheral response to exogenous catecholamines, in turn explaining stable mHbO 2 in response to epinephrine and norepinephrine during propofol anaesthesia. However, these explanations remain unproven.
Clinical implication
Extrapolation to the clinical setting suggests that norepinephrine may preserve or increase (depending on selected dose, and type of anaesthesia) microcirculatory mucosal oxygenation in anaesthetized subjects without disturbed vasoregulation. These beneficial regional effects appear to be associated with markedly less alterations in systemic circulation and metabolism, compared with epinephrine. Epinephrine in contrast failed to increase microcirculatory mucosal oxygenation, despite marked systemic effects in our study. Regional mucosal effects of norepinephrine and epinephrine are not predicted by their systemic effects and regional effects of vasoactive drugs depend on the type of baseline anaesthesia, for example, volatile or i.v. Further studies are required.
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online.
